KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northrop Grumman (NOC) Cash & Equivalents (2016 - 2025)

Northrop Grumman has reported Cash & Equivalents over the past 17 years, most recently at $4.4 billion for Q4 2025.

  • Quarterly results put Cash & Equivalents at $4.4 billion for Q4 2025, up 1.15% from a year ago — trailing twelve months through Dec 2025 was $4.4 billion (up 1.15% YoY), and the annual figure for FY2025 was $4.4 billion, up 1.15%.
  • Cash & Equivalents for Q4 2025 was $4.4 billion at Northrop Grumman, up from $2.0 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for NOC hit a ceiling of $4.4 billion in Q4 2025 and a floor of $1.2 billion in Q2 2022.
  • Median Cash & Equivalents over the past 5 years was $3.1 billion (2023), compared with a mean of $2.9 billion.
  • Biggest five-year swings in Cash & Equivalents: crashed 70.34% in 2022 and later soared 189.48% in 2023.
  • Northrop Grumman's Cash & Equivalents stood at $3.5 billion in 2021, then decreased by 27.0% to $2.6 billion in 2022, then increased by 20.64% to $3.1 billion in 2023, then surged by 40.01% to $4.4 billion in 2024, then grew by 1.15% to $4.4 billion in 2025.
  • The last three reported values for Cash & Equivalents were $4.4 billion (Q4 2025), $2.0 billion (Q3 2025), and $1.9 billion (Q2 2025) per Business Quant data.